INSIGHTS

A Texas judge's dismissal of WCAS from an FTC antitrust case ensures investor liability standards nationwide.

As waistlines have expanded, so has the list of proposed solutions to the obesity crisis – yet nearly all have fallen short. Enter GLP-1s, the new heavyweight champions in the battle against obesity and diabetes. Stakeholders across the healthcare industry – from health plans and employers to pharma companies and patients – are scurrying to determine the potential ripple effects. At nearly $1,000 a month, GLP-1s like Ozempic, Wegovy, and Mounjaro are not just thinning waistl

Navigating the interactions between stakeholders in the healthcare landscape is crucial for the commercial success of any drug launch. This network of relationships and negotiations significantly impacts treatment outcomes, drug pricing, and market access. At the heart of this ecosystem are Pharmacy Benefit Managers (PBMs) whose role is pivotal yet often misunderstood. As intermediaries between health plans, drug manufacturers, and pharmacies, PBMs are tasked with a crucial

After more than two years in the doldrums, initial public offerings, an important indicator of the biotechnology industry’s health, have shown signs of life.   The theme of biotech having turned the corner is echoed by a number of industry investors. In Barbara Ryan’s column in Pharmaceutical Executive in March, she outlines a number of reasons for investor optimism: Investors belief that interest rates will come down in 2024 Compelling clinical data A red-hot M&A market   A

In exploring the intricate web of interconnected systems within our bodies, we often overlook the silent powerhouse known as the enteric nervous system (ENS). While the heart and blood vessels take the spotlight in discussions about cardiovascular health, the ENS quietly influences various aspects of our well-being, including the functioning of our cardiovascular system.  The ENS, often dubbed the "second brain," is a sophisticated network of neurons nestled within our...

BOSTON, February 27, 2024 -- Brooks Hill Partners, Red Team Associates, and Solstice Strategy Group have joined forces to form Spinnaker...